TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $560 | +2.0% | 36,284 | +1.2% | 0.01% | +8.3% |
| Q2 2023 | $549 | -14.2% | 35,863 | -7.6% | 0.01% | -20.0% |
| Q1 2023 | $640 | -2.9% | 38,798 | -8.2% | 0.02% | -6.2% |
| Q4 2022 | $659 | -99.9% | 42,279 | +7.0% | 0.02% | +14.3% |
| Q3 2022 | $513,000 | +6.4% | 39,519 | +15.2% | 0.01% | +16.7% |
| Q2 2022 | $482,000 | -3.0% | 34,290 | -1.2% | 0.01% | +9.1% |
| Q1 2022 | $497,000 | +2.9% | 34,720 | -2.1% | 0.01% | +10.0% |
| Q4 2021 | $483,000 | -16.4% | 35,460 | +0.5% | 0.01% | -28.6% |
| Q3 2021 | $578,000 | +2.7% | 35,290 | +5.6% | 0.01% | +7.7% |
| Q2 2021 | $563,000 | -7.4% | 33,430 | +0.4% | 0.01% | -13.3% |
| Q1 2021 | $608,000 | -23.3% | 33,300 | -23.5% | 0.02% | -25.0% |
| Q4 2020 | $793,000 | +11.2% | 43,550 | +8.9% | 0.02% | 0.0% |
| Q3 2020 | $713,000 | -3.4% | 39,990 | -2.8% | 0.02% | -9.1% |
| Q2 2020 | $738,000 | – | 41,150 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |